Ying-Ping Jiang

Statistics

Publications

Citations

485

H-Index

Active since

2017

Affiliations

Cellerant Therapeutics (United States)(Current)

SciGenom Labs (India)

University of Virginia

Nanyang Technological University

University of Toronto

Ying-Ping Jiang is an author at Cellerant Therapeutics (United States) specializing in pharmacology, molecular virology, and host receptor polymorphisms.

Publications per year

2017–2021

Publications

Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2

Kushal Suryamohan, Devan Diwanji, Eric Stawiski et al. · Communications Biology · 2021 · 233 citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Biology +17

Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility

Eric Stawiski, Devan Diwanji, Kushal Suryamohan et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 157 citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Genetics +16

CLT030, a leukemic stem cell–targeting CLL1 antibody-drug conjugate for treatment of acute myeloid leukemia

Ying-Ping Jiang, Bob Y. Liu, Quan Zheng et al. · Blood Advances · 2018 · 69 citations · Full text

Medicine, Oncology, Pharmacology +16

Design and Synthesis of Isoquinolidinobenzodiazepine Dimers, a Novel Class of Antibody–Drug Conjugate Payload

Sean W. Smith, Vasu Jammalamadaka, Dmitry Borkin et al. · ACS Medicinal Chemistry Letters · 2017 · 14 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Surface‐Functionalized Carrier‐Free Drug Nanorods for Leukemia

Vinu Krishnan, Apoorva Sarode, Rohit Bhatt et al. · Advanced Therapeutics · 2018 · 12 citations

Pharmacy, Pharmaceutics, Pharmacology +17

1–5 of 5